Live better. Live longer.
Bristlecone Pacific is a venture capital fund investing in innovative companies with world-class teams, developing evidence-based solutions to extend healthy human lifespan.
We believe new interventions, backed by scientific evidence, will enable humans to control the biological aging process and be youthful at any age.
about anchor
Our Focus Areas
“It is not an unreasonable expectation for anyone who is alive and healthy today to reach 100 in good health - active and engaged at levels we’d expect of healthy 50-year olds today.”
Harvard Medical School genetics professor and “Lifespan” author, Dr. David Sinclair
team anchor
Meet The Team
General Partner, Vancouver BC
Serial sports tech founder & CEO
Seasoned early stage VC
Angel investor and board member
General Partner, Copenhagen DK
AI and biotech executive
(led NASDAQ IPO)
Medical doctor, specialized in oncology
Angel investor and board member
Principal, Vancouver BC
Strategy & CorpDev executive
(start-ups to Fortune 100)
Ex-McKinsey
Angel investor and Advisor
Scientific Advisors
Leading researcher on aging & neurodegenerative disease
Over 590 journal publications
Head of Molecular Genetics Lab at NIH for 30 years
Co-founder & Chief AI Officer at Evaxion (NASDAQ: EVAX)
Expert on AI, bioinformatics and in silico platforms
Focused on longevity and immune system applications
Investment and Business Advisors
Serial entrepreneur & investor in tech and biotech
Facilitating technology and pharma investments in Asia-Pacific
Founder & Chief Investment Officer – ISAR Capital Partners
20 years investment management experience
Founder – Nordic Investment Partners
35 years experience in global equities (investment banking, asset management, investor relations) and board roles
Senior Fellow at the Council on Strategic Risks
Assistant Secretary of Defense for NCB Programs under President Obama
Advisor on transformative technologies within biology for public & private sector